Bivalirudin in acute coronary syndromes.
Bonvini
Robert F
RF
Verin
Vitali
V
Righini
Marc
M
D000707:Anaphylaxis / Q000139:chemically induced*; D000789:Angina, Unstable / Q000188:drug therapy*; D000917:Antibody Formation; D000925:Anticoagulants / Q000276:immunology* / Q000627:therapeutic use; D003429:Cross Reactions; D004359:Drug Therapy, Combination; D006629:Hirudins / Q000276:immunology*; D006801:Humans; D010446:Peptide Fragments / Q000276:immunology* / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000276:immunology / Q000627:therapeutic use
D000925:Anticoagulants; D006629:Hirudins; D010446:Peptide Fragments; D011994:Recombinant Proteins; C074619:bivalirudin